$600 Withings Scale Flags Heart, Diabetes Risk in 90 Seconds

$600 Withings Scale Flags Heart, Diabetes Risk in 90 Seconds

> At a Glance

> – Withings Body Scan 2 smart scale tracks 60 biomarkers in 90 seconds for $600

> – Measures heart health, metabolic aging, and early blood-sugar warning signs

> – FDA clearance pending; launch slated for Q2 2026

> – Why it matters: Brings hospital-grade longevity tests to your bathroom

Withings unveiled Body Scan 2 at CES 2026, turning a bathroom scale into an “at-home longevity station” that claims to spot early signs of hypertension and prediabetes without cuffs or needles.

How It Works

smart

A retractable handlebar with four steel electrodes pairs with eight others under the tempered-glass platform. Together they feed five medical-grade sensors normally found only in clinics. After a 90-second weigh-in, data syncs over Wi-Fi or Bluetooth to the Withings app on iPhone or Android.

What It Measures

The scale buckets its 60 biomarkers into three groups:

  • Heart & vascular: cuff-free blood-pressure risk, arterial stiffness, cardiac output
  • Cellular & metabolic: mitochondrial efficiency, cellular aging pace
  • Diet & glycemic: early glycemic dysregulation that can precede diabetes

The app converts these into a personalized Health Trajectory score that ignores daily weight swings and instead charts long-term direction.

Privacy, Price, Release

Withings says the device complies with GDPR and HIPAA and holds ISO 27001 and ISO 27701 security certifications. It runs on a rechargeable battery rated for up to 15 months per charge.

Region Price
US $600
UK £450
AU AU$899

Body Scan 2 is pending FDA clearance for select metrics and is expected to ship in Q2 2026 through Withings, Amazon, and select retailers.

Key Takeaways

  • 60 biomarkers distilled into one trend-based Health Trajectory score
  • Early warning system for hypertension and prediabetes without extra gear
  • $600 price positions it as a premium wellness tool, not a casual scale
  • 15-month battery and robust privacy certs aim to ease adoption hurdles

If the FDA signs off, Withings’ $600 scale could make daily, clinic-grade longevity tracking as routine as brushing your teeth.

Author

  • My name is Amanda S. Bennett, and I am a Los Angeles–based journalist covering local news and breaking developments that directly impact our communities.

    Amanda S. Bennett covers housing and urban development for News of Los Angeles, reporting on how policy, density, and displacement shape LA neighborhoods. A Cal State Long Beach journalism grad, she’s known for data-driven investigations grounded in on-the-street reporting.

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *